Effects on Gastric Circulation of Treatment for Portal Hypertension in Cirrhosis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 1998 Jul 4

PMID 9635622

Citations 2

Authors

S Sezai

M Ito

Y Sakurai

K Kamisaka

T Abe

F Ikegami

Y Yamamoto

M Hirano

Affiliations

Soon will be listed here.

Abstract

We evaluated the gastric circulatory effects of the type of treatment administered for portal hypertension. Of 14 patients with cirrhosis, seven received a transjugular intrahepatic portosystemic shunt (TIPS; group T) and seven received percutaneous transhepatic portographic embolization (PTPE; group P). Patients were evaluated over the course of one year. After treatment, portal venous pressure was significantly reduced from 39 +/- 6 cm H2O to 32 +/- 5 (P < 0.001) in group T and was significantly elevated from 29 +/- 10 to 33 +/- 8 (P < 0.05) in group P. The portal flow velocity (Vmean) was significantly higher in group T vs group P (P < 0.0001). The congestion index was significantly lower in group T than in group P (P < 0.0001). The gastric mucosal blood flow was increased in group T but was unchanged in group P. Esophageal varices showed some improvement in both groups, but the portal hypertensive gastropathy was improved only in group T. These findings help to explain the differing effects on the gastric circulation related to the type of treatment used for portal hypertension.

Citing Articles

Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Gjeorgjievski M, Cappell M World J Hepatol. 2016; 8(4):231-62.

PMID: 26855694 PMC: 4733466. DOI: 10.4254/wjh.v8.i4.231.

Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Burak K, Lee S, Beck P Gut. 2001; 49(6):866-72.

PMID: 11709525 PMC: 1728555. DOI: 10.1136/gut.49.6.866.

References

Sarin S, Sreenivas D, Lahoti D, Saraya A . Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology. 1992; 102(3):994-9. DOI: 10.1016/0016-5085(92)90188-5. View

Iwao T, Toyonaga A, Sumino M, Takagi K, OHO K, NISHIZONO M . Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology. 1992; 102(6):2060-5. DOI: 10.1016/0016-5085(92)90332-s. View

Payen J, Cales P, Voigt J, Barbe S, Pilette C, Dubuisson L . Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995; 108(1):138-44. DOI: 10.1016/0016-5085(95)90018-7. View

Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Zozaya J . Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 1995; 21(4):986-94. View

Iwao T, Toyonaga A, Ikegami M, OHO K, Sumino M, Harada H . Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy. Hepatology. 1993; 18(1):36-40. View

Yamamoto Y, Sezai S, Sakurabayashi S, Hirano M, Oka H . Effect of hepatic collateral hemodynamics on gastric mucosal blood flow in patients with liver cirrhosis. Dig Dis Sci. 1992; 37(9):1319-23. DOI: 10.1007/BF01295998. View

Ohta M, Hashizume M, Higashi H, Ueno K, Tomikawa M, Kishihara F . Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology. 1994; 20(6):1432-6. DOI: 10.1002/hep.1840200609. View

Somberg K, Lake J, Tomlanovich S, Laberge J, Feldstein V, Bass N . Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology. 1995; 21(3):709-16. View

Sezai S, Hirano M, Kamisaka K . Case report: percutaneous transhepatic portographic embolization (PTPE) for recurrent hepatic encephalopathy derived from intrahepatic portal-systemic shunts. Clin Radiol. 1995; 50(11):807-9. DOI: 10.1016/s0009-9260(05)83228-3. View

10.

McCormack T, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson A . Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?. Gut. 1985; 26(11):1226-32. PMC: 1432906. DOI: 10.1136/gut.26.11.1226. View

11.

Lunderquist A, VANG J . Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med. 1974; 291(13):646-9. DOI: 10.1056/NEJM197409262911303. View

12.

Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L . Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med. 1995; 122(11):816-22. DOI: 10.7326/0003-4819-122-11-199506010-00002. View

13.

Moller S, Sondergaard L, Mogelvang J, Henriksen O, Henriksen J . Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology. 1995; 22(2):472-8. DOI: 10.1002/hep.1840220216. View

14.

Panes J, Bordas J, Pique J, Bosch J, Garcia-Pagan J, Feu F . Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology. 1992; 103(6):1875-82. DOI: 10.1016/0016-5085(92)91447-c. View

15.

Papazian A, Braillon A, Dupas J, Sevenet F, Capron J . Portal hypertensive gastric mucosa: an endoscopic study. Gut. 1986; 27(10):1199-203. PMC: 1433869. DOI: 10.1136/gut.27.10.1199. View

16.

Almond N, Wheatley A . Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol. 1992; 262(2 Pt 1):G203-9. DOI: 10.1152/ajpgi.1992.262.2.G203. View

17.

DAmico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spano C . Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology. 1990; 99(6):1558-64. DOI: 10.1016/0016-5085(90)90458-d. View

18.

Ferral H, Bjarnason H, Wegryn S, Rengel G, Nazarian G, Rank J . Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology. 1993; 189(3):795-801. DOI: 10.1148/radiology.189.3.8234706. View

19.

Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau J . The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994; 330(3):165-71. DOI: 10.1056/NEJM199401203300303. View

20.

Pique J, Bosch J, Panes J, Gonzalez A, Perez R, Rigau J . Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991; 337(8755):1431-4. DOI: 10.1016/0140-6736(91)93125-s. View